• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Genetic Tests

Genomics plc & GSK Partner to Optimize Clinical Trials with Genetic Risk Testing

by Jasmine Pennic 04/30/2024 Leave a Comment

Genomics plc & GSK Partner to Optimize Clinical Trials with Genetic Risk Testing

What You Should Know:  - Genomics plc, a leader in polygenic risk score (PRS) technology, and pharmaceutical giant GSK inks a new collaboration to explore the potential of PRS for optimizing clinical trial design.  - The innovative approach could revolutionize the way researchers select patients and ultimately lead to faster development of new treatments. Unlocking the Power of Genetics for Clinical Trials Genomics plc brings its expertise in PRS technology to the table.
Read More

Hartwig Medical, Ultima Genomics Partner to Transform Precision Oncology with Affordable Genetic Testing

by Jasmine Pennic 04/08/2024 Leave a Comment

Hartwig Medical, Ultima Genomics Partner to Transform Precision Oncology with Affordable Genetic Testing

What You Should Know:  - Hartwig Medical Foundation, a provider in using comprehensive genetic profiling to improve cancer treatment, and Ultima Genomics, a developer of groundbreaking next-generation sequencing (NGS) technology, announce a groundbreaking collaboration.  - The strategic partnership aims to make whole genome sequencing, the most detailed form of genetic analysis, a more accessible and affordable tool in the fight against cancer. The Challenge: High Costs Limit
Read More

What Impact Could AI Have On Genetic Testing?

by Dr Rocío Acuña Hidalgo, co-founder and CTO at Nostos Genomics 02/27/2023 Leave a Comment

What Impact Could AI Have On Genetic Testing?

The sequencing and analysis of human DNA have advanced significantly since the initial draft of a human genome that was published as part of the Human Genome Project. With DNA sequencing becoming increasingly cost-effective, the market for genetic testing is growing at an accelerating rate – the market for Next Generation Sequencing (NGS) services has an estimated annual growth of 18.3% from 2022 to 2030. AI presents a range of possibilities for this rapidly growing field, and in this article,
Read More

Why Families Need the Closure Whole Genome Sequencing Provides

by Haim Neerman, CEO of Variantyx 03/25/2021 Leave a Comment

Why Families Need the Closure Whole Genome Sequencing Provides

For medical practitioners expertly trained in the scientific methods of discovery, having a young patient with serious health complications from an undiagnosed condition is about as somber and frustrating as it gets. These feelings are only magnified for parents of the patient, especially when searching for a diagnosis can go on for years. This is the essence of what is known as the “diagnostic odyssey.” Honing in on a rare disease diagnosis involves thorough medical history evaluations,
Read More

Eliminating the Long, Cumbersome and Costly Diagnosis of Genetic Diseases

by Christine Stanley, Ph.D.,Chief Director of Clinical Genomics for Variantyx 07/01/2020 Leave a Comment

Eliminating the Long, Cumbersome and Costly Diagnosis of Genetic Diseases

The answer to questions about human disease can be found in our genes. The difficulty in the past has been the testing process, a sort of trial and error approach of drilling down into the multitude of variants that can be found within the genes, variants that when analyzed in tandem with detailed clinical histories can actually tell the story and lead to a faster diagnosis. Human beings carry around 20,000 genes and, of those, approximately 5,000 are somewhat understood, and those genes can
Read More

Consumer Genetic Tests Accelerate Precision Medicine for Some Providers

by Joel Diamond, MD, FAAFP, Chief Medical Officer at 2bPrecise 06/09/2020 Leave a Comment

Consumer Genetic Tests Accelerate Precision Medicine for Some Providers

Direct-to-consumer (DTC) genetic tests have been on the scene for some time now. The Federal Drug Administration (FDA) approved the first DTC test on three specific BRCA1/BRCA2 breast cancer gene mutations more than two years ago. Six months after that, the agency similarly green-lighted a DTC pharmacogenomic (PGx) test to examine 33 variants for eight different genes that indicate how effectively patients metabolize specific medications. Like many such advances, availability of DTC tests is
Read More

Mount Sinai Researchers Develops AI Algorithm to Detect COVID-19 from CT Scans

by Fred Pennic 05/20/2020 Leave a Comment

Mount Sinai Researchers Develops AI Algorithm to Detect COVID-19 from CT Scans

What You Should Know: - Mount Sinai researchers develop a unique artificial intelligence (AI) algorithm to detect COVID-19 based on CT scans and patient data. - The Mount Sinai team integrated data from those CT scans with the clinical information to develop an AI algorithm. It mimics the workflow a physician uses to diagnose COVID-19 and gives a final prediction of positive or negative diagnosis.  Mount Sinai researchers are the first in the country to use
Read More

CVS Health Launches Transform Oncology Care Program, Partners with Tempus

by Jasmine Pennic 12/12/2019 Leave a Comment

CVS Health Launches Transform Oncology Care Program, Partners with Tempus

- CVS Health launches Transform Oncology Care, which includes a comprehensive, first-of-its-kind precision medicine approach to oncology management for payors in collaboration with Tempus.- Transform Oncology Care includes an innovative precision medicine strategy that increases access to broad-panel gene sequencing tests for patients diagnosed with certain advanced-stage cancers. - The program also uses CVS’ local footprint and unique assets to improve patient outcomes and lower costs every
Read More

Ambry Genetics Launches Paired RNA and DNA Testing for Hereditary Cancer

by Fred Pennic 10/01/2019 Leave a Comment

Ambry Genetics Launches Paired RNA and DNA Testing for Hereditary Cancer

- Ambry launches a new genetic test, +RNAinsight that changes the standard for “clinical grade” testing, with higher accuracy.- +RNAinsight enables clinicians – for the first time ever – to conduct both DNA and RNA genetic testing at the same time.- Ambry is the first and only lab to offer paired RNA and DNA genetic testing for hereditary cancer.Ambry Genetics (Ambry), a clinical genetic testing company, announced today the launch of +RNAinsight, a major advancement in genetic testing.
Read More

StartUp Health Adds 6 New Healthcare Transformers to its Portfolio

by Fred Pennic 07/25/2019 Leave a Comment

StartUp Health Adds 6 New Healthcare Transformers to its Portfolio

StartUp Health, a platform where health transformers, partners, customers, investors, patients, and caregivers connect and accelerate the progress of the health moonshots announced it has added six new companies to its army of Healthcare Transformers.Every quarter, StartUp Health coaches its army of Health Transformers on how to create value, amplify their story, and ultimately achieve their Health Moonshot. Each company is supported for the entire journey of their business, through multiple
Read More

  • Go to page 1
  • Go to page 2
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |